Phenylbutyric acid suppresses protein accumulation-mediated ER stress in retrovirus-infected astrocytes and delays onset of paralysis in infected mice.
Many neurodegenerative diseases are associated with accumulation of misfolded proteins in cells of the central nervous system (CNS). We have previously reported that accumulation of the precursor envelope protein gPr80(env) of ts1, a mutant of Moloney murine leukemia virus (MoMuLV), in the endoplasmic reticulum (ER) of infected astrocytes, results in ER stress, oxidative stress and cell death, subsequently leading to ts1-mediated neurodegeneration in infected mice. In the present study, we assessed whether treatments that reduce the accumulation of gPr80(env) in the ER of ts1-infected astrocytes provided a protective effect against ER stress and cell death. We show that treatment with phenylbutyric acid (PBA) can prevent the unfolded protein response (UPR), ER stress and cell death in cultured ts1-infected astrocytes. The protective effect of PBA is associated with its ability to reduce gPr80(env) accumulation and to increase the expression of proteins involved in protein folding in the ER, such as protein disulfide isomerase (PDI) and ERp44, rather than by decrease mRNA levels of gPr80(env) or alter the proteasomal degradation process for gPr80(env). In infected mice treated with PBA we also noted a reduction in the severity of the neuropathology in brainstem tissues and a delayed onset of paralysis. These results show that PBA is a potentially effective drug for the treatment of neurodegeneration caused by protein accumulation in cells of the CNS.
Kuang
Xianghong
X
Department of Carcinogenesis, The University of Texas, MD Anderson Cancer Center, Science Park-Research Division, Smithville, TX 78957, USA.
Hu
Wenhui
W
Yan
Mingshan
M
Wong
Paul K Y
PK
D000818:Animals; D000831:Animals, Newborn; D001253:Astrocytes / Q000187:drug effects* / Q000473:pathology / Q000821:virology; D002461:Cell Line, Transformed; D002478:Cells, Cultured; D004721:Endoplasmic Reticulum / Q000187:drug effects* / Q000473:pathology / Q000821:virology; D051379:Mice; D008979:Moloney murine leukemia virus; D041681:NIH 3T3 Cells; D018384:Oxidative Stress / Q000187:drug effects* / Q000502:physiology; D010243:Paralysis / Q000517:prevention & control* / Q000821:virology; D010654:Phenylbutyrates / Q000494:pharmacology* / Q000627:therapeutic use; D012190:Retroviridae; D012192:Retroviridae Infections / Q000473:pathology / Q000517:prevention & control* / Q000821:virology; D014764:Viral Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism
D010654:Phenylbutyrates; D014764:Viral Proteins
Antioxid Redox Signal. 2009 Oct;11(10):2409-27
19388824
AIDS. 2005 Jan 28;19(2):127-35
15668537
Nat Rev Immunol. 2008 Sep;8(9):663-74
18670423
Proc Natl Acad Sci U S A. 2004 Aug 17;101(33):12300-5
15295099
Semin Cell Dev Biol. 2007 Dec;18(6):716-31
18023214
Neuropathol Appl Neurobiol. 2007 Dec;33(6):658-69
17931354
Anesth Analg. 2004 Dec;99(6):1708-1714
15562059
Nat Med. 2010 Apr;16(4):396-9
20376052
Immunol Lett. 2009 Feb 21;122(2):159-69
19183564
Exp Gerontol. 2006 Apr;41(4):380-6
16564150
Nature. 2008 Jul 24;454(7203):455-62
18650916
Lab Invest. 2004 Jul;84(7):816-27
15094714
Plant Cell. 2003 Feb;15(2):561-76
12566592
J Immunol. 2007 Jul 15;179(2):1210-24
17617614
Acta Neuropathol. 2000 Mar;99(3):238-44
10663965
Brain Res. 2009 Aug 25;1286:174-84
19523933
Mol Neurobiol. 2009 Apr;39(2):81-9
19184563
Hum Mol Genet. 2008 Sep 1;17(17):2610-21
18508857
J Virol. 2006 May;80(9):4557-69
16611916
Methods Enzymol. 2008;442:395-419
18662581
Cell Stress Chaperones. 1996 Jun;1(2):109-15
9222596
J Neurovirol. 2004 Jun;10(3):189-98
15204924
J Virol. 1990 Feb;64(2):467-75
2296075
Curr Mol Med. 2006 Feb;6(1):37-43
16472111
Science. 2006 Aug 25;313(5790):1137-40
16931765
J Virol. 2005 May;79(9):5585-93
15827173
Neoplasia. 2008 Feb;10(2):160-7
18283338
J Neurochem. 2006 Jun;97(5):1259-68
16539653
Parkinsonism Relat Disord. 2009 Nov;15(9):649-54
19345133
Genome Biol. 2001;2(6):REVIEWS1017
11423012
Apoptosis. 2009 Mar;14(3):309-19
19184438
J Neurovirol. 2002 Aug;8(4):318-25
12161816
J Virol. 2004 Nov;78(21):11926-38
15479833
Neuromolecular Med. 2003;4(1-2):21-36
14528050
Biochem J. 2001 Apr 1;355(Pt 1):19-28
11256944
Lab Invest. 2002 Jun;82(6):693-702
12065679
Antioxid Redox Signal. 2009 Sep;11(9):2119-34
19243238
Brain. 2007 Dec;130(Pt 12):3111-23
17716997
Science. 2008 Feb 15;319(5865):916-9
18276881
Brain Res. 1998 Jan 1;779(1-2):1-8
9473560
Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15428-33
12434014
Ann Neurol. 2009 Aug;66(2):253-8
19743454
Curr Med Chem. 2009;16(5):615-26
19199926
Viral Immunol. 2001;14(2):95-109
11398815
Nat Cell Biol. 2000 Jun;2(6):326-32
10854322
Neuropsychopharmacology. 2009 Jun;34(7):1721-32
19145227
Nat Rev Drug Discov. 2008 Dec;7(12):1013-30
19043451
Mol Cell Biol. 2009 Aug;29(15):4295-307
19470760
Nat Neurosci. 2004 Oct;7(10):1088-95
15452578
Virus Res. 1991 Mar;19(1):83-92
1867010
FASEB J. 1993 Dec;7(15):1515-7
7903263
Leukemia. 1992;6 Suppl 3:161S-165S
1602815
J Virol. 2006 Apr;80(7):3273-84
16537594
Am J Respir Crit Care Med. 1998 Feb;157(2):484-90
9476862
FEBS Lett. 2007 Jul 31;581(19):3641-51
17481612
J Neurol Neurosurg Psychiatry. 1998 Jul;65(1):29-33
9667557
Curr Mol Med. 2008 May;8(3):157-72
18473817
J Neuroimmune Pharmacol. 2009 Jun;4(2):190-9
19288297
J Virol. 2009 Jun;83(12):6079-86
19339354
Blood. 1995 Jan 1;85(1):43-9
7528572
Mol Cell Biol. 2001 Feb;21(4):1249-59
11158311
Trends Neurosci. 2001 Mar;24(3):162-9
11182456
Cancer Chemother Pharmacol. 2005 Mar;55(3):203-12
15570424
Mol Biol Cell. 1999 Nov;10(11):3787-99
10564271
Immunol Lett. 2009 Feb 21;122(2):150-8
19186189
Curr Mol Med. 2004 Jun;4(4):397-403
15354870
Nature. 2001 Feb 15;409(6822):860-921
11237011
Cell Death Differ. 2006 Mar;13(3):363-73
16397583
Cell Death Differ. 2006 Mar;13(3):385-92
16397584
EMBO J. 2008 Jan 23;27(2):336-49
18216876
Virology. 2006 May 10;348(2):398-405
16466764
J Neurochem. 2007 Jun;101(6):1491-1504
17459145
Exp Anim. 2009 Apr;58(2):113-21
19448334
Invest Ophthalmol Vis Sci. 2007 Apr;48(4):1683-90
17389500
Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18525-30
19011102
J Virol. 2008 Mar;82(5):2586-9
18077710
Arch Anat Cytol Pathol. 1997;45(2-3):94-105
9382615
Nat Rev Mol Cell Biol. 2007 Jul;8(7):519-29
17565364
J Virol. 1993 Mar;67(3):1137-47
8437206
J Neurovirol. 1997 Feb;3(1):28-37
9147819
Neurochem Int. 2010 May-Jun;56(6-7):780-8
20211212
J Neurovirol. 1997 Aug;3(4):274-82
9291235
Mol Cells. 2007 Oct 31;24(2):261-7
17978580